320 related articles for article (PubMed ID: 15812959)
1. The unexamined assumptions of intellectual property: adopting an evaluative approach to patenting biotechnological innovation.
Gold ER; Adams W; Castle D; de Langavant GC; Cloutier LM; Daar AS; Glass A; Smith PJ; Bernier L
Public Aff Q; 2004 Oct; 18(4):299-344. PubMed ID: 15812959
[No Abstract] [Full Text] [Related]
2. The gene patenting controversy: a convergence of law, economic interests, and ethics.
Kevles DJ; Berkowitz A
Brooklyn Law Rev; 2001; 67(1):233-48. PubMed ID: 12645549
[No Abstract] [Full Text] [Related]
3. Biomedical patents and ethics: a Canadian solution.
Gold ER
McGill Law J; 2000 May; 45(2):413-35. PubMed ID: 12688288
[TBL] [Abstract][Full Text] [Related]
4. Patenting DNA: who defines and protects the public good?
Garcia SA
Am J Bioeth; 2002; 2(3):25-6. PubMed ID: 12230850
[No Abstract] [Full Text] [Related]
5. Churches say no to gene patenting.
Christ Century; 2000 Sep; 117(25):899-900. PubMed ID: 12528735
[No Abstract] [Full Text] [Related]
6. Biotechnology patenting policy in the European Union--as exemplified by the development in Germany.
Schrell A; Bauser H; Brunner H
Adv Biochem Eng Biotechnol; 2007; 107():13-39. PubMed ID: 17522818
[TBL] [Abstract][Full Text] [Related]
7. Innovations and intellectual property: the case of genomic patenting.
Jackson BA
J Policy Anal Manage; 2003; 22(1):5-25. PubMed ID: 12722760
[TBL] [Abstract][Full Text] [Related]
8. Patenting pluripotence: the next battle for stem cell intellectual property.
Vrtovec KT; Scott CT
Nat Biotechnol; 2008 Apr; 26(4):393-5. PubMed ID: 18392018
[TBL] [Abstract][Full Text] [Related]
9. International conflicts over patenting human DNA sequences in the United States and the European Union: an argument for compulsory licensing and a fair-use exemption.
Gitter DM
N Y Univ Law Rev; 2001 Dec; 76(6):1623-91. PubMed ID: 12741387
[TBL] [Abstract][Full Text] [Related]
10. Should genes be patented? The gene patenting controversy: legal, ethical, and policy foundations of an international agreement.
Looney B
Law Policy Int Bus; 1994; 26(1):231-72. PubMed ID: 11979605
[No Abstract] [Full Text] [Related]
11. Patenting the parts.
Nat Biotechnol; 2007 Aug; 25(8):822. PubMed ID: 17687343
[No Abstract] [Full Text] [Related]
12. Patents on parts of the human body: salient issues under EC and WTO law.
Herdegen M
J World Intellect Prop; 2002 Mar; 5(2):145-55. PubMed ID: 15986546
[No Abstract] [Full Text] [Related]
13. Patent first, ask questions later: morality and biotechnology in patent law.
Bagley MA
William Mary Law Rev; 2003 Dec; 45(2):469-547. PubMed ID: 15570677
[TBL] [Abstract][Full Text] [Related]
14. [Biotechnological invention patents: a legal-economic analysis].
Pérez-Bustamante G
Rev Derecho Genoma Hum; 1998; (8):159-86. PubMed ID: 15839032
[TBL] [Abstract][Full Text] [Related]
15. Patenting Foundational Technologies: Lessons From CRISPR and Other Core Biotechnologies.
Feeney O; Cockbain J; Morrison M; Diependaele L; Van Assche K; Sterckx S
Am J Bioeth; 2018 Dec; 18(12):36-48. PubMed ID: 31159699
[TBL] [Abstract][Full Text] [Related]
16. Why the European Parliament rejected the patenting of human genes.
Grace M
Gene Ther; 1995 Oct; 2(8):509-11. PubMed ID: 8593600
[No Abstract] [Full Text] [Related]
17. Patenting life: a view from the constitution and beyond.
Schneider CA; Cohn F; Bonner C
Whittier Law Rev; 2002; 24(2):385-416. PubMed ID: 15085853
[No Abstract] [Full Text] [Related]
18. The morality of biotech patents: differing legal obligations in Europe?
Ford R
Eur Intellect Prop Rev; 1997 Jun; 19(6):315-8. PubMed ID: 16538738
[No Abstract] [Full Text] [Related]
19. Towards harmonization: the European biotechnology patent directive.
Curley D
J Biolaw Bus; 2002; 5(3):64-8. PubMed ID: 12816122
[TBL] [Abstract][Full Text] [Related]
20. Ethical aspects of patenting human genotypes according to EC Biotechnology Directive.
Spranger TM
IIC Int Rev Ind Prop Copyr Law; 2000 Jun; 31(4):373-80. PubMed ID: 12956125
[No Abstract] [Full Text] [Related]
[Next] [New Search]
